Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter Clinical Study in Chinese Subjects to Compare the Safety and Efficacy of the Delta PLUS Femoral Head and SL-TWIN Stem With BIOLOX Forte Ball Head and SL-PLUS Stem in Total Hip Arthroplasty

NCT02347384 is registered in ClinicalTrials.gov with Smith & Nephew Orthopaedics (Beijing) Limited as lead sponsor.

NCT NCT02347384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02347384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter Clinical Study in Chinese Subjects to Compare the Safety and Efficacy of the Delta PLUS Femoral Head and SL-TWIN Stem With BIOLOX Forte Ball Head and SL-PLUS Stem in Total Hip Arthroplasty
Lead sponsor
Smith & Nephew Orthopaedics (Beijing) Limited
Phase
Not applicable
Overall status
Completed
Start date
April 20, 2015
Completion date
November 1, 2016
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, developmental dysplasia of the hip, femoral neck fracture, osteoarthritis, post-traumatic arthritis, rheumatoid arthritis